Why the MGC Pharma (ASX:MXC) share price is 31% higher today

The MGC Pharma (ASX: MXC) share price flew up more than 35% higher today, cementing gains after an exclusive supply deal announced yesterday.

| More on:

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More

The MGC Pharmaceuticals Ltd (ASX: MXC) share price zoomed up more than 35% higher today off the back of a positive announcement released to the market yesterday.  

In a strong finish at the close of trade today, the MCG Pharma share price was trading at 12.5 cents, up 31.58%.

What's fuelling the MGC Pharma share price?

MGC Pharma advised the market yesterday that it had entered a sale and distribution agreement for its anti-inflammatory medicinal cannabis product.

According to the release, MGC has entered an exclusive, 3-year agreement with European nutraceuticals producer Swiss PharmaCan AG (SPC).

The deal will see SPC exclusively sell and distribute MGC's food supplement ArtemiC product line. In addition, SPC will be responsible for obtaining all relevant permits, approvals, certificates and licences and customs clearances under the distribution deal.

The agreement also includes a minimum wholesale order quantity to MGC of 40,000 units of ArtmiC Rescue per quarter. The initial distribution deal is worth $1.1 million, with SPC taking delivery of 10,000 units of ArtemiC.

MGC Pharma says the agreement will allow the company direct access to large and rapidly growing markets.

ArtemiC completes COVID-19 trial

The distribution agreement with SPC follows MGC's completion of the Phase 2 clinical trial for ArtemiC Rescue.

In the trial results, ArtemiC Rescue demonstrated the ability to prevent deterioration in patients with COVID-19 and achieve faster clinical improvements.

The trial, conducted on 50 COVID-19 patients in India and Israel, also resulted in reduced symptoms and pain associated with the virus.

The clinically-tested food supplement contains four natural-based ingredients: Artemisinin, Boswellia serrata, curcumin and vitamin C.

How has the MGC Pharma share price responded?

Including today's price action, the MGC Pharma share price has surged more than 78% since the announcement was released early yesterday.  

Overall, it's been a significant month for the company, which has seen the MGC Pharma share price surge more than 350% since the start of February.

The company made headlines earlier this month after listing on the London Stock Exchange (LSE).

In addition, MGC Pharma completed a successful capital raise of £6.5 million through an oversubscribed share placement. The company advised that the capital raise proceeds were being used to meet costs associated with clinical trials for its ArtemiC and CannEpil products.

Motley Fool contributor Nikhil Gangaram has no position in any of the stocks mentioned. The Motley Fool Australia has no position in any of the stocks mentioned. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Bruce Jackson.

More on Share Market News

Woman with a scared look has hands on her face.
Share Fallers

These were the worst performing ASX 200 shares in July

Let's see why investors were selling off these shares last month.

Read more »

A team of people giving the thumbs up sign representing APA and Wesfarmers doing a deal to study green hydrogen transport using an APA gas pipeline
Broker Notes

9 ASX 200 shares attracting 'strong buy' ratings from the experts

There is a consensus 'strong buy rating' on these stocks from analysts on the CommSec trading platform.

Read more »

A cute little kid in a suit pulls a shocked face as he talks on his smartphone.
Broker Notes

What does Macquarie expect from Telstra shares this earnings season?

Telstra shares are up 22% so far in 2025.

Read more »

A neon sign says 'Top Ten'.
Share Gainers

Here are the top 10 ASX 200 shares today

It was a disappointing end to the trading week this Friday.

Read more »

A woman reaches her arms to the sky as a plane flies overhead at sunset.
Broker Notes

Macquarie predicts 25% upside for Flight Centre shares

Flight Centre shares have had a bumpy ride in 2025, but Macquarie sees clear skies ahead.

Read more »

A woman sits at her computer with her chin resting on her hand as she contemplates her next potential investment.
Opinions

Should you hold on to these 4 ASX 200 outperformers or take your profits and run?

Should you hold on to these ASX stocks after outstanding growth or take your profits and run?

Read more »

Young people shopping in mall and having fun.
Broker Notes

7 ASX retail shares to buy as Aussies start spending again: experts

The Australian Bureau of Statistics reported a 'retail sales surge' in June with 1.2% higher turnover.

Read more »

Miner and company person analysing results of a mining company.
Broker Notes

Why Macquarie just raised its price target for Rio Tinto shares

Macquarie offers its verdict on Rio-Tinto shares following the half-year results.

Read more »